Vortex Imaging announced the closing of a $12 million financing round supported by existing and new investors, including 10D Ventures, Entrée Capital, Harel T.E.C Partnership, Connecticut Innovations, and PhiFund Ventures.
The financing will support the continued development, regulatory clearance, and commercialization of Vortex Imaging’s computational ultrasound system, a novel imaging platform designed to deliver high-quality 3D volumetric imaging at the point of care through computational image reconstruction technology utilizing GPUs-on-Cloud.
The company is developing a compact ultrasound-based imaging system intended to bring advanced 3D volumetric imaging into everyday clinical environments. Vortex Imaging aims to reduce variability associated with traditional ultrasound workflows by enabling standardized and reproducible volumetric datasets with a reduced learning curve while avoiding ionizing radiation and large imaging infrastructure.
The reconstructed images are designed to provide physicians with advanced 3D volumetric visualization capabilities in a format traditionally associated with CT and MRI systems while maintaining the accessibility, portability, and safety advantages of ultrasound.
The company also announced expanded board leadership as part of the financing. Ori Hadomi has been appointed Chairman of the Board. Hadomi currently serves as Vice President of Strategic Initiatives & Partnerships at Medtronic and brings experience scaling medical technologies from development through commercialization.
Additional board members include Chris Cleary, former Vice President of Corporate Development at Medtronic and former executive at GE Healthcare; Yahal Zilka, co-founder and Managing Partner at 10D Ventures; and Dr. Yael Grunbaum, Partner at Entrée Capital and Head of Entrée Bio.
Vortex Imaging’s initial clinical focus will target urology and nephrology, with plans to expand into additional diagnostic and procedural applications in the future.
KEY QUOTES:
“Vortex is focused on transforming ultrasound from a highly operator-dependent modality into a standardized, volumetric imaging system capable of delivering advanced 3D clinical insights directly at the point of care. We are excited to have the support of experienced investors and board members as we continue advancing toward FDA clearance and initial clinical deployment.”
Tomer Ben David, CEO, Vortex Imaging
“Vortex Imaging has the potential to significantly expand how and where advanced imaging is performed. The combination of high-quality volumetric imaging, reduced operator dependency, and a compact ultrasound-based platform could enable a far more scalable and standardized approach to imaging across healthcare systems.”
Ori Hadomi, Chairman of the Board, Vortex Imaging
